Current financial headlines
Sharemaestro Newsreel
Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.
- Showing
- 613–648
- Headlines
- 5371
- Sources here
- 20
- Companies here
- 28
Chronological news
Earlier headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
iRhythm Technologies (NASDAQ:IRTC) Given Average Recommendation of "Moderate Buy" by Analysts
Analysts have given iRhythm Technologies (NASDAQ:IRTC) an average recommendation of "Moderate Buy," with a consensus price target of $179.93. The company recently reported strong quarterly earnings, beating expectations with an EPS of $0.58 and revenue of $224.17 million, a 20.1% year-over-year increase. Institutional investors, …
Abbott Laboratories (NYSE:ABT) Receives Consensus Rating of "Moderate Buy" from Brokerages
Abbott Laboratories (NYSE:ABT) has received a consensus "Moderate Buy" rating from twenty-six brokerages, with an average 12-month price target of $118.17. The company recently exceeded quarterly expectations with adjusted EPS of $1.31 and revenue of $12.59 billion, and announced a quarterly dividend of $0.63 …
1 Semiconductor Stock for Long-Term Investors and 2 Facing Challenges
1 Semiconductor Stock for Long-Term Investors and 2 Facing Challenges Semiconductors are the silicon backbone of the digital revolution. The amount of data we ingest is also increasing exponentially, leading to elevated demand for chips with more processing power. This secular trend bodes well …
ATEC Stock Price and Chart — NASDAQ:ATEC
This article provides a detailed overview of Alphatec Holdings, Inc. (NASDAQ:ATEC) stock, including its current price, historical performance, key financial metrics, and analyst ratings. It highlights the company's focus on spinal fusion technology and reports its Q2 2026 earnings, showing revenue growth and increased …
1 Cash-Heavy Stock with Exciting Potential and 2 We Question
1 Cash-Heavy Stock with Exciting Potential and 2 We Question Companies with more cash than debt can be financially resilient, but that doesn't mean they're all strong investments. Some lack leverage because they struggle to grow or generate consistent profits, making them unattractive borrowers. …
SS Innovations Appoints Sarah M. Romano as Chief Financial Officer
SS Innovations International, Inc. (Nasdaq: SSII), a developer of surgical robotic technologies, has appointed Sarah M. Romano as its new Chief Financial Officer, effective August 3, 2026. Romano brings over two decades of experience in financial leadership, capital strategy, and corporate growth within the …
Inspire medical systems chief mfg. officer Kelly sells $57,346 in stock
Jason P. Kelly, Chief Manufacturing and Quality Officer at Inspire Medical Systems (NASDAQ:INSP), sold 963 shares of company stock for a total of $57,346. Following the sale, Mr. Kelly directly owns 18,985 shares. Despite the stock being down 36% year-to-date, InvestingPro analysis suggests the …
Owlet Inc (OWLT) (Q2 2026) Earnings Call Highlights: Record Revenue and Strategic AI Expansion ...
This article first appeared on GuruFocus. Release Date: August 11, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Record Q2 total revenue of $33.9 million, up 29.9% year-over-year. Gross margin expanded to 54% …
Mobia Medical Inc (MOBI) (Q2 2026) Earnings Call Highlights: Revenue Surges 102% as IPO Fuels ...
Mobia Medical Inc. (MOBI) reported a 102% year-over-year revenue increase to $13.5 million in Q2 2026, driven by an IPO that raised $134 million and expanded active territories. Despite the strong revenue growth and improved gross margin, the company's net loss widened to $21.0 …
SINTX Technologies Provides Mid-Year 2026 Business Update Highlighting Commercial Execution, Biomaterial Platform Expansion and Strategic Growth Initiatives
SINTX Technologies released its mid-year 2026 business update, detailing significant progress in commercializing its FDA-cleared SiNAPTIC® Foot & Ankle Implant System and expanding its industrial ceramics business with $3.2 million in new purchase orders. The company also raised $5.0 million in capital, completed construction …
Edwards Lifesciences (EW) Insider Daniel Lippis Sells 619 Shares
Edwards Lifesciences insider Daniel Lippis sold 619 shares of EW stock for $92.03 per share on August 11, 2026, totaling approximately $56,966.57. This sale is part of a pattern of 37 insider sells and no buys over the last year. Despite the insider selling, …
Tranche Update on MaxCyte, Inc.'s Equity Buyback Plan announced on May 12, 2026.
MaxCyte, Inc. has provided an update on its equity buyback plan announced on May 12, 2026. As of August 12, 2026, the company has repurchased 4,730,105 shares, representing 4.42% of its stock, for a total of $5.5 million. This repurchase completes the program initiated …
Alamar Biosciences (ALMR): Qiming funds report over 10% ownership stake
Qiming funds have reported a significant ownership stake in Alamar Biosciences, Inc. (ALMR) through a Schedule 13G filing. Qiming Corporate GP VI, Ltd and related entities collectively hold 10.2% beneficial ownership, translating to 7,066,573 shares based on 69,311,186 shares outstanding as of April 30, …
Tandem Diabetes Care, Inc. (TNDM) Investor Outlook: Analyzing 25% Potential Upside with No Sell Ratings
Tandem Diabetes Care, Inc. (TNDM) presents a high-risk, high-reward investment opportunity in the medical devices industry, with analysts projecting a 25% potential upside and no sell ratings. Despite current financial challenges like negative EPS and free cash flow, the company is bullishly positioned above …
908 Devices Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:MASS) 2026-08-11
908 Devices Inc. (MASS) reported strong Q2 2026 results with a 23% revenue increase to $16.1 million, driven by demand from US state and local customers. The company significantly improved profitability, cutting adjusted EBITDA loss by over 50% year-over-year, and raised its full-year 2026 …
Sintx Technologies Q2 2026 Earnings Call Transcript
Sintx Technologies reported significant revenue growth of 199% year-over-year in Q2 2026, reaching $452,000, driven by increased product sales and improved gross margins. The company highlighted over $3.2 million in new purchase orders for contract manufacturing and initial commercial revenue from its SINAPTIC Foot …
Does Medtronic (MDT) Still Trade At A Discount After Its CE Mark Win?
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Medtronic stock has delivered a 20.8% gain over the past three years, yet current checks suggest it now sits close to its estimated …
Alphatec (ATEC) Q2 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026, at 4:30 p.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer - Patrick MilesExecutive Vice President and Chief Financial Officer - J. Todd Koning TAKEAWAYS Total Revenue -- $214 million in the second quarter, …
Owlet Q2 Earnings Call Highlights
This article first appeared on GuruFocus. Release Date: August 11, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Record Q2 total revenue of $33.9 million, up 29.9% year-over-year. Gross margin expanded to 54% …
ENvue Medical Ord Shs (FEED) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for ENvue Medical Ord Shs (FEED), detailing its stock performance, market capitalization, and a comparison with peer companies. The financial forecasting includes expected EPS, revenue, net profit, and EBIT. It highlights that the data was updated on August …
Inspire Medical Systems (NYSE:INSP) Insider Jason Kelly Sells 963 Shares of Stock
Inspire Medical Systems insider Jason Kelly sold 963 shares of the company's stock for approximately $57,346.65, reducing his holdings by 4.83%. The company recently reported better-than-expected quarterly earnings and revenue, but revenue was down 7.6% year-over-year. Analysts maintain a "Hold" rating on the stock …
SINTX Technologies Q2 Results: Revenue guidance set at $900K-$1.1M for Q3
SINTX Technologies (NASDAQ: SINT) announced strong commercial progress in mid-2026, securing $3.2 million in new industrial orders and expanding its orthopedic distributor network for the SiNAPTIC implant system. The company set Q3 2026 revenue guidance between $900K and $1.1 million and Q4 guidance between …
ETFs Investing in TransMedics Group, Inc. Stocks
This article lists various Exchange Traded Funds (ETFs) that hold stocks of TransMedics Group, Inc. The ETFs are primarily small-cap and health technology focused, providing investors with diversified exposure to the company. The list includes details such as market value, weight of TransMedics stock, …
Medtronic options activity shows heavy call buying ahead of September earnings
Ahead of its September 1 earnings, Medtronic (NYSE:MDT) has seen significant options activity, with call volume far outpacing puts. Nearly 19,000 contracts for a single $100 call option for September 2026 indicate strong bullish sentiment, suggesting traders anticipate a substantial upside surprise. This event-driven …
CeriBell (CBLL) Stock Premium Rides High Margins Despite Deeper Losses
CeriBell (CBLL) stock saw a 10.4% increase after its Q2 earnings report, driven by headline growth in its high-margin medical device business, despite widened net losses. The company reported revenue of US$28.1m and a net loss of US$19.3m, with investors crediting progress in hospital …
DexCom’s 37.5% quarter puts CGM maker within 3.5% of its high as volume stays moderate
DexCom closed at $84.75 after a ninth week in an active Trend Signal, but participation is only 1.1x baseline and the signal mix is balanced rather than emphatic.
Apyx Medical Sees GLP-1 Boom Fueling Demand for Renuvion, AYON Body Contouring
Apyx Medical is leveraging the increasing demand for surgical aesthetic procedures, driven by GLP-1 weight-loss drugs, with its Renuvion technology and new AYON Body Contouring System. The company projects significant revenue growth for 2026 in surgical aesthetics and is focusing on expanding its product …
UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring the 9.23% Potential Upside in the Booming Medical Devices Sector
UFP Technologies, Inc. (UFPT) is presented as an appealing investment opportunity in the medical devices sector, boasting a $2.52 billion market cap and strong revenue growth of 15.10%. The company specializes in designing and manufacturing solutions for various medical devices, including advanced wound care …
Tenon Medical Announces Reverse Stock Split to Maintain Listing
Tenon Medical, Inc. (TNON) has announced a 1-for-35 reverse stock split, effective August 10, 2026, to meet Nasdaq's minimum $1.00 per-share requirement and maintain its listing. The company specializes in medical devices for sacro-pelvic disorders, marketing the Catamaran and SImmetry+ SI Joint Fusion Systems. …
PRCT Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against PROCEPT BioRobotics Corporation and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit
Robbins Geller Rudman & Dowd LLP has filed a class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) on behalf of investors who purchased stock between February 28, 2024, and February 25, 2026. The lawsuit alleges that PROCEPT made materially false and misleading statements …
LivaNova PLC (LIVN) employee stock rights lead to 2,675-share sale
LivaNova PLC has reported a planned sale of 2,675 shares of common stock, stemming from the exercise of employee stock appreciation rights. The transaction, valued at $209,942.40, is scheduled for August 11, 2026, and will be executed through Merrill Lynch as a broker-assisted cashless …